{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T12:06:38Z","timestamp":1788264398794,"version":"build-2803163510"},"reference-count":43,"publisher":"Zhejiang University Press","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1631\/jzus.b2400509","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:47:29Z","timestamp":1765932449000},"page":"1216-1232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Depleting CBR1 increases chemosensitivity by reducing stemness and quiescence traits in non-small cell lung cancer","CBR1 \u901a\u8fc7\u8c03\u8282\u7ec6\u80de\u5e72\u6027\u548c\u9759\u6b62\u72b6\u6001\u4ecb\u5bfc\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u5316\u7597\u654f\u611f\u6027"],"prefix":"10.1631","volume":"26","author":[{"given":"Weiwen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6396-4339","authenticated-orcid":false,"given":"Kejing","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"635","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"issue":"1\u20133","key":"509_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cbi.2008.10.058","volume":"178","author":"JE Bray","year":"2009","unstructured":"Bray JE, Marsden BD, Oppermann U, 2009. The human short-chain dehydrogenase\/reductase (SDR) superfamily: a bioinformatics summary. Chem Biol Interact, 178(1\u20133): 99\u2013109. https:\/\/doi.org\/10.1016\/j.cbi.2008.10.058","journal-title":"Chem Biol Interact"},{"issue":"7834","key":"509_CR2","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1038\/d41586-020-03152-0","volume":"587","author":"H Brody","year":"2020","unstructured":"Brody H, 2020. Lung cancer. Nature, 587(7834):S7. https:\/\/doi.org\/10.1038\/d41586-020-03152-0","journal-title":"Nature"},{"issue":"9","key":"509_CR3","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.stemcr.2022.07.017","volume":"17","author":"SL Cai","year":"2022","unstructured":"Cai SL, Yang YS, Ding YF, et al., 2022. SETD4 cells contribute to brain development and maintain adult stem cell reservoir for neurogenesis. Stem Cell Reports, 17(9):2081\u20132096. https:\/\/doi.org\/10.1016\/j.stemcr.2022.07.017","journal-title":"Stem Cell Reports"},{"issue":"9\u201310","key":"509_CR4","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1007\/s10495-023-01855-z","volume":"28","author":"G Chen","year":"2023","unstructured":"Chen G, Zhang HH, Sun HX, et al., 2023a. Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K\/AKT\/mTOR signal pathway. Apoptosis, 28(9\u201310):1390\u20131405. https:\/\/doi.org\/10.1007\/s10495-023-01855-z","journal-title":"Apoptosis"},{"issue":"1","key":"509_CR5","doi-asserted-by":"publisher","first-page":"2200036","DOI":"10.1002\/prca.202200036","volume":"17","author":"G Chen","year":"2023","unstructured":"Chen G, Yang LN, Liu GX, et al., 2023b. Research progress in protein microarrays: focussing on cancer research. Proteom Clin Appl, 17(1):2200036. https:\/\/doi.org\/10.1002\/prca.202200036","journal-title":"Proteom Clin Appl"},{"issue":"9","key":"509_CR6","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41419-021-04116-6","volume":"12","author":"KC Chen","year":"2021","unstructured":"Chen KC, Zhang CZ, Ling SB, et al., 2021. The metabolic flexibility of quiescent CSC: implications for chemotherapy resistance. Cell Death Discov, 12(9):835. https:\/\/doi.org\/10.1038\/s41419-021-04116-6","journal-title":"Cell Death Discov"},{"issue":"7","key":"509_CR7","doi-asserted-by":"publisher","first-page":"e00453","DOI":"10.1128\/MCB.00453-16","volume":"37","author":"L Dai","year":"2017","unstructured":"Dai L, Ye S, Li HW, et al., 2017. SETD4 regulates cell quiescence and catalyzes the trimethylation of H4K20 during diapause formation in Artemia. Mol Cell Biol, 37(7):e00453\u201316. https:\/\/doi.org\/10.1128\/MCB.00453-16","journal-title":"Mol Cell Biol"},{"issue":"15","key":"509_CR8","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/onc.2011.384","volume":"31","author":"L Galluzzi","year":"2012","unstructured":"Galluzzi L, Senovilla L, Vitale I, et al., 2012. Molecular mechanisms of cisplatin resistance. Oncogene, 31(15): 1869\u20131883. https:\/\/doi.org\/10.1038\/onc.2011.384","journal-title":"Oncogene"},{"key":"509_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bcp.2018.12.010","volume":"160","author":"WS Heng","year":"2019","unstructured":"Heng WS, Gosens R, Kruyt FAE, 2019. Lung cancer stem cells: origin, features, maintenance mechanisms and therapeutic targeting. Biochem Pharmacol, 160:121\u2013133. https:\/\/doi.org\/10.1016\/j.bcp.2018.12.010","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"509_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.tibs.2013.09.004","volume":"38","author":"HM Herz","year":"2013","unstructured":"Herz HM, Garruss A, Shilatifard A, 2013. SET for life: biochemical activities and biological functions of SET domain-containing proteins. Trends Biochem Sci, 38(12):621\u2013639. https:\/\/doi.org\/10.1016\/j.tibs.2013.09.004","journal-title":"Trends Biochem Sci"},{"issue":"23","key":"509_CR11","doi-asserted-by":"publisher","first-page":"5245","DOI":"10.1158\/1078-0432.CCR-14-3160","volume":"21","author":"Y Iwamoto","year":"2015","unstructured":"Iwamoto Y, Mitsudomi T, Sakai K, et al., 2015. Randomized phase II study of adjuvant chemotherapy with long-term S-1 versus cisplatin+S-1 in completely resected stage II-IIIA non-small cell lung cancer. Clin Cancer Res, 21(23):5245\u20135252. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-3160","journal-title":"Clin Cancer Res"},{"issue":"16","key":"509_CR12","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1158\/0008-5472.CAN-12-1110","volume":"72","author":"M Jang","year":"2012","unstructured":"Jang M, Kim Y, Won H, et al., 2012. Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide. Cancer Res, 72(16):4214\u20134224. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-1110","journal-title":"Cancer Res"},{"key":"509_CR13","doi-asserted-by":"publisher","first-page":"598620","DOI":"10.3389\/fcell.2020.598620","volume":"8","author":"X Jiang","year":"2020","unstructured":"Jiang X, Li Y, Feng JL, et al., 2020. Safrana l prevents prostate cancer recurrence by blocking the re-activation of quiescent cancer cells via downregulation of S-phase kinase-associated protein 2. Front Cell Dev Biol, 8:598620. https:\/\/doi.org\/10.3389\/fcell.2020.598620","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"509_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1089\/ars.2015.6457","volume":"26","author":"A Jo","year":"2017","unstructured":"Jo A, Choi TG, Jo YH, et al., 2017. Inhibition of carbonyl reductase 1 safely improves the efficacy of doxorubicin in breast cancer treatment. Antioxid Redox Sign, 26(2):70\u201383. https:\/\/doi.org\/10.1089\/ars.2015.6457","journal-title":"Antioxid Redox Sign"},{"issue":"3","key":"509_CR15","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.toxlet.2012.04.006","volume":"211","author":"JL Kalabus","year":"2012","unstructured":"Kalabus JL, Cheng QY, Jamil RG, et al., 2012. Induction of carbonyl reductase 1 (CBR1) expression in human lung tissues and lung cancer cells by the cigarette smoke constituent benzo[a]pyrene. Toxicol Lett, 211 (3):266\u2013273. https:\/\/doi.org\/10.1016\/j.toxlet.2012.04.006","journal-title":"Toxicol Lett"},{"issue":"24","key":"509_CR16","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1007\/s00018-008-8588-y","volume":"65","author":"KL Kavanagh","year":"2008","unstructured":"Kavanagh KL, J\u00f6rnvall H, Persson B, et al., 2008. Medium- and short-chain dehydrogenase\/reductase gene and protein families: the SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes. Cell Mol Life Sci, 65(24):3895. https:\/\/doi.org\/10.1007\/s00018-008-8588-y","journal-title":"Cell Mol Life Sci"},{"key":"509_CR17","doi-asserted-by":"publisher","first-page":"105511","DOI":"10.1016\/j.ejps.2020.105511","volume":"154","author":"P Koczurkiewicz-Adamczyk","year":"2020","unstructured":"Koczurkiewicz-Adamczyk P, Piska K, Gunia-Krzy\u017cak A, et al., 2020. Cinnamic acid derivatives as chemosensitising agents against DOX-treated lung cancer cells\u2013involvement of carbonyl reductase 1. Eur J Pharm Sci, 154:105511. https:\/\/doi.org\/10.1016\/j.ejps.2020.105511","journal-title":"Eur J Pharm Sci"},{"key":"509_CR18","doi-asserted-by":"publisher","first-page":"120777","DOI":"10.1016\/j.lfs.2022.120777","volume":"305","author":"P Koczurkiewicz-Adamczyk","year":"2022","unstructured":"Koczurkiewicz-Adamczyk P, G\u0105siorkiewicz B, Piska K, et al., 2022. Cinnamamide derivatives with 4-hydroxypiperidine moiety enhance effect of doxorubicin to cancer cells and protect cardiomyocytes against drug-induced toxicity through CBR1 inhibition mechanism. Life Sci, 305:120777. https:\/\/doi.org\/10.1016\/j.lfs.2022.120777","journal-title":"Life Sci"},{"issue":"10","key":"509_CR19","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1111\/j.1349-7006.2008.00903.x","volume":"99","author":"S Lal","year":"2008","unstructured":"Lal S, Sandanaraj E, Wong ZW, et al., 2008. CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients. Cancer Sci, 99(10):2045\u20132054. https:\/\/doi.org\/10.1111\/j.1349-7006.2008.00903.x","journal-title":"Cancer Sci"},{"issue":"4","key":"509_CR20","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1007\/s12015-021-10121-1","volume":"17","author":"XM Liao","year":"2021","unstructured":"Liao XM, Wu CX, Shao ZM, et al., 2021. SETD4 in the proliferation, migration, angiogenesis, myogenic differentiation and genomic methylation of bone marrow mesenchymal stem cells. Stem Cell Rev Rep, 17(4):1374\u20131389. https:\/\/doi.org\/10.1007\/s12015-021-10121-1","journal-title":"Stem Cell Rev Rep"},{"issue":"22","key":"509_CR21","doi-asserted-by":"publisher","first-page":"10650","DOI":"10.1111\/jcmm.17002","volume":"25","author":"AJ Massey","year":"2021","unstructured":"Massey AJ, Benwell K, Burbridge M, et al., 2021. Targeting DYRK1A\/B kinases to modulate p21-cyclin D1-p27 signalling and induce anti-tumour activity in a model of human glioblastoma. J Cell Mol Med, 25(22):10650\u201310662. https:\/\/doi.org\/10.1111\/jcmm.17002","journal-title":"J Cell Mol Med"},{"issue":"9","key":"509_CR22","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1248\/bpb.b15-00176","volume":"38","author":"T Matsunaga","year":"2015","unstructured":"Matsunaga T, Kezuka C, Morikawa Y, et al., 2015. Up-regulation of carbonyl reductase 1 renders development of doxorubicin resistance in human gastrointestinal cancers. Biol Pharm Bull, 38(9):1309\u20131319. https:\/\/doi.org\/10.1248\/bpb.b15-00176","journal-title":"Biol Pharm Bull"},{"key":"509_CR23","doi-asserted-by":"publisher","first-page":"n2363","DOI":"10.1136\/bmj.n2363","volume":"375","author":"M Miller","year":"2021","unstructured":"Miller M, Hanna N, 2021. Advances in systemic therapy for non-small cell lung cancer. BMJ, 375:n2363. https:\/\/doi.org\/10.1136\/bmj.n2363","journal-title":"BMJ"},{"issue":"9","key":"509_CR24","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3390\/jpm11090852","volume":"11","author":"J Morin-Buote","year":"2021","unstructured":"Morin-Buote J, Ennour-Idrissi K, Poirier \u00c9, et al., 2021. Association of breast tumour expression of cannabinoid receptors CBR1 and CBR2 with prognostic factors and survival in breast cancer patients. J Pers Med, 11(9):852. https:\/\/doi.org\/10.3390\/jpm11090852","journal-title":"J Pers Med"},{"issue":"11","key":"509_CR25","doi-asserted-by":"publisher","first-page":"113347","DOI":"10.1016\/j.celrep.2023.113347","volume":"42","author":"D Mukhopadhyay","year":"2023","unstructured":"Mukhopadhyay D, Goel HL, Xiong CA, et al., 2023. The calcium channel TRPC6 promotes chemotherapy-induced persistence by regulating integrin a6 mRNA splicing. Cell Rep, 42(11):113347. https:\/\/doi.org\/10.1016\/j.celrep.2023.113347","journal-title":"Cell Rep"},{"issue":"1","key":"509_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.canlet.2012.03.035","volume":"323","author":"A Murakami","year":"2012","unstructured":"Murakami A, Yakabe K, Yoshidomi K, et al., 2012. Decreased carbonyl reductase 1 expression promotes malignant behaviours by induction of epithelial mesenchymal transition and its clinical significance. Cancer Lett, 323(1):69\u201376. https:\/\/doi.org\/10.1016\/j.canlet.2012.03.035","journal-title":"Cancer Lett"},{"key":"509_CR27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.lungcan.2020.01.008","volume":"141","author":"S Niho","year":"2020","unstructured":"Niho S, Yoshida T, Akimoto T, et al., 2020. Randomized phase II study of chemoradiotherapy with cisplatin + S-1 versus cisplatin + pemetrexed for locally advanced non-squamous non-small cell lung cancer: SPECTRA study. Lung Cancer, 141:64\u201371. https:\/\/doi.org\/10.1016\/j.lungcan.2020.01.008","journal-title":"Lung Cancer"},{"issue":"1","key":"509_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1146\/annurev.pharmtox.47.120505.105316","volume":"47","author":"U Oppermann","year":"2007","unstructured":"Oppermann U, 2007. Carbonyl reductases: the complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology. Annu Rev Pharmacol Toxicol, 47(1):293\u2013322. https:\/\/doi.org\/10.1146\/annurev.pharmtox.47.120505.105316","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"509_CR29","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.3892\/ijo.2014.2810","volume":"46","author":"Y Osawa","year":"2015","unstructured":"Osawa Y, Yokoyama Y, Shigeto T, et al., 2015. Decreased expression of carbonyl reductase 1 promotes ovarian cancer growth and proliferation. Int J Oncol, 46(3):1252\u20131258. https:\/\/doi.org\/10.3892\/ijo.2014.2810","journal-title":"Int J Oncol"},{"issue":"13","key":"509_CR30","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1002\/1873-3468.13867","volume":"594","author":"BR Pennycook","year":"2020","unstructured":"Pennycook BR, Barr AR, 2020. Restriction point regulation at the crossroads between quiescence and cell proliferation. FEBS Lett, 594(13):2046\u20132060. https:\/\/doi.org\/10.1002\/1873-3468.13867","journal-title":"FEBS Lett"},{"key":"509_CR31","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.cbi.2019.01.003","volume":"300","author":"K Piska","year":"2019","unstructured":"Piska K, Koczurkiewicz P, Wnuk D, et al., 2019. Synergistic anticancer activity of doxorubicin and piperlongumine on DU-145 prostate cancer cells\u2013the involvement of carbonyl reductase 1 inhibition. Chem Biol Interact, 300:40\u201348. https:\/\/doi.org\/10.1016\/j.cbi.2019.01.003","journal-title":"Chem Biol Interact"},{"issue":"3","key":"509_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ijc.2910450304","volume":"45","author":"JJ Schlager","year":"1990","unstructured":"Schlager JJ, Powis G, 1990. Cytosolic NAD(P)H:(Quinone-acceptor)oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol. Int J Cancer, 45(3):403\u2013409. https:\/\/doi.org\/10.1002\/ijc.2910450304","journal-title":"Int J Cancer"},{"issue":"8","key":"509_CR33","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1080\/17425255.2017.1356820","volume":"13","author":"SM Shi","year":"2017","unstructured":"Shi SM, Di L, 2017. The role of carbonyl reductase 1 in drug discovery and development. Expert Opin Drug Metab Toxicol, 13(8):859\u2013870. https:\/\/doi.org\/10.1080\/17425255.2017.1356820","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"509_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, et al., 2021. Cancer statistics, 2021. CA A Cancer J Clin, 71(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21654","journal-title":"CA A Cancer J Clin"},{"issue":"2","key":"509_CR35","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jhep.2010.06.045","volume":"54","author":"E Tak","year":"2011","unstructured":"Tak E, Lee S, Lee J, et al., 2011. Human carbonyl reductase 1 upregulated by hypoxia renders resistance to apoptosis in hepatocellular carcinoma cells. J Hepatol, 54(2):328\u2013339. https:\/\/doi.org\/10.1016\/j.jhep.2010.06.045","journal-title":"J Hepatol"},{"key":"509_CR36","doi-asserted-by":"publisher","first-page":"7367854","DOI":"10.1155\/2023\/7367854","volume":"2023","author":"YH Wang","year":"2023","unstructured":"Wang YH, Yu YM, Yang WJ, et al., 2023. SETD4 confers cancer stem cell chemoresistance in nonsmall cell lung cancer patients via the epigenetic regulation of cellular quiescence. Stem Cells Int, 2023:7367854. https:\/\/doi.org\/10.1155\/2023\/7367854","journal-title":"Stem Cells Int"},{"issue":"18","key":"509_CR37","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1158\/0008-5472.CAN-19-1084","volume":"79","author":"S Ye","year":"2019","unstructured":"Ye S, Ding YF, Jia WH, et al., 2019. SET domain-containing protein 4 epigenetically controls breast cancer stem cell quiescence. Cancer Res, 79(18):4729\u20134743. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-1084","journal-title":"Cancer Res"},{"key":"509_CR38","doi-asserted-by":"publisher","first-page":"1141331","DOI":"10.3389\/fcell.2023.1141331","volume":"11","author":"HH Zhang","year":"2023","unstructured":"Zhang HH, Zhang Z, Guo TT, et al., 2023a. Annexin A protein family: focusing on the occurrence, progression and treatment of cancer. Front Cell Dev Biol, 11:1141331. https:\/\/doi.org\/10.3389\/fcell.2023.1141331","journal-title":"Front Cell Dev Biol"},{"key":"509_CR39","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1186\/s12967-023-04613-6","volume":"21","author":"HH Zhang","year":"2023","unstructured":"Zhang HH, Dong XL, Ding XY, et al., 2023b. Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt\/\u03b2-catenin signal pathway. J Transl Med, 21:900. https:\/\/doi.org\/10.1186\/s12967-023-04613-6","journal-title":"J Transl Med"},{"key":"509_CR40","doi-asserted-by":"publisher","first-page":"7155525","DOI":"10.1155\/2022\/7155525","volume":"2022","author":"YJ Zhang","year":"2022","unstructured":"Zhang YJ, Zhang HX, Zhang XL, et al., 2022. CBR3-AS1 accelerates the malignant proliferation of gestational choriocarcinoma cells by stabilizing SETD4. Dis Markers, 2022: 7155525. https:\/\/doi.org\/10.1155\/2022\/7155525","journal-title":"Dis Markers"},{"key":"509_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molimm.2019.07.011","volume":"114","author":"YY Zhong","year":"2019","unstructured":"Zhong YY, Ye P, Mei ZZ, et al., 2019. The novel methyltransferase SETD4 regulates TLR agonist-induced expression of cytokines through methylation of lysine 4 at histone 3 in macrophages. Mol Immunol, 114:179\u2013188. https:\/\/doi.org\/10.1016\/j.molimm.2019.07.011","journal-title":"Mol Immunol"},{"key":"509_CR42","doi-asserted-by":"publisher","first-page":"114813","DOI":"10.1016\/j.bcp.2021.114813","volume":"193","author":"L Zhou","year":"2021","unstructured":"Zhou L, Yang C, Zhong WL, et al., 2021. Chrysin induces autophagy-dependent ferroptosis to increase chemosensitivity to gemcitabine by targeting CBR1 in pancreatic cancer cells. Biochem Pharmacol, 193:114813. https:\/\/doi.org\/10.1016\/j.bcp.2021.114813","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"509_CR43","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.3892\/mmr.2016.5605","volume":"14","author":"SX Zhu","year":"2016","unstructured":"Zhu SX, Xu YP, Song M, et al., 2016. PRDM16 is associated with evasion of apoptosis by prostatic cancer cells according to RNA interference screening. Mol Med Rep, 14(4): 3357\u20133361. https:\/\/doi.org\/10.3892\/mmr.2016.5605","journal-title":"Mol Med Rep"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2400509.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1631\/jzus.B2400509","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B2400509.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:02:07Z","timestamp":1768338127000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1631\/jzus.B2400509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["509"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b2400509","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"14 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Weiwen LI, Jialu ZHAO, Weihong LAN, Xiaofei YE, and Kejing YING declare that they have no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}},{"value":"This study was performed in line with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Approval was granted by the Ethics Committee of the Fifth Affiliated Hospital of Wenzhou Medical University (No. 2020D133).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethics guidelines"}}]}}